1 completed, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Delusions: new trials by email Literature Review of Delusions trials Research Report on Delusions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pimavanserin for Sleep in Parkinson Disease Pimavanserin - Parkinson Disease | Early Phase 1 | Withdrawn | State University of New York - Downstate Medical Center | 2023-01-27 | 2024-12-20 | |
| Intervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study) Feel-Good- Group - Early Psychosis, Delusions | Early Phase 1 | Completed | Philipps University Marburg | 36 | 2021-01-08 | 2022-05-05 |
Emotional Regulation (1) · Hallucinations (1) · Parkinson Disease (1) · Psychotic Disorders (1)
Behavior (2) · Behavioral Symptoms (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Mental Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Parkinsonian Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Inosine Monophosphate (1) · pimavanserin (1)
Philipps University Marburg (1) · State University of New York - Downstate Medical Center (1)
Germany (1) · United States (1)
Andreas Bechdolf, MD (1) · Christian J Amlang, MD (1) · Karolina Leopold, MD (1) · Nikola M Stenzel, Ph. D. (1)